drugset / Trial / NCT06434636

The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon Satisfaction

NCT06434636

Completed 100 enrolled TC Erciyes University
RandomizedParallel-groupSingle-blindPrevention

Summary

By using tranexamic acid, an antifibrinolytic drug, the aim is to prevent the restriction of the field of view of the surgical field due to bleeding in middle ear microscopic and endoscopic surgery operations in which controlled hypotension is applied, and therefore the prolongation of the surgical time, and to increase surgeon satisfaction.

Timeline

Start
2024-12-01
Primary completion
2025-05-05
Completion
2025-08-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 10 mg/kg Intravenous

Indications